Latest Ratios: P/E Ratio 11.4x · EV/EBITDA 5.1x · ROE 14.6%. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.5B | $2.0B | $3.3B | $2.1B | $2.2B | $1.2B | — | — |
| Enterprise Value | $2.2B | $2.7B | $3.9B | $2.8B | $2.8B | $2.5B | — | — |
| P/E Ratio → | 11.38 | 14.95 | 11.01 | 8.28 | 18.27 | 3.71 | — | — |
| P/S Ratio | 0.43 | 0.59 | 0.88 | 0.56 | 0.59 | 0.43 | — | — |
| P/B Ratio | 1.56 | 2.04 | 3.92 | 2.33 | 3.18 | 6.74 | — | — |
| P/FCF | 33.09 | 44.87 | 13.38 | 7.13 | 7.47 | 2.56 | — | — |
| P/OCF | 5.43 | 7.37 | 7.08 | 4.16 | 4.93 | 2.24 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.80 | 1.04 | 0.76 | 0.78 | 0.87 | — | — |
| EV / EBITDA | 5.08 | 6.29 | 6.50 | 5.19 | 4.41 | 5.44 | — | — |
| EV / EBIT | 8.73 | 11.03 | 8.55 | 6.61 | 5.25 | 6.87 | — | — |
| EV / FCF | — | 61.19 | 15.80 | 9.65 | 9.79 | 5.14 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 21.9% | 21.9% | 24.9% | 24.5% | 27.8% | 24.2% | 19.1% | 34.3% |
| Operating Margin | 7.4% | 7.4% | 11.8% | 10.8% | 14.8% | 11.6% | 3.8% | 12.4% |
| Net Profit Margin | 3.9% | 3.9% | 8.0% | 6.8% | 3.3% | 11.7% | 7.1% | 9.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | 14.6% | 14.6% | 34.6% | 32.0% | 27.4% | 28.9% | 7.3% | 15.0% |
| ROA | 4.9% | 4.9% | 11.0% | 9.1% | 4.4% | 12.0% | 5.3% | 10.9% |
| ROIC | 11.9% | 11.9% | 21.6% | 20.2% | 29.0% | 14.0% | 3.0% | 15.2% |
| ROCE | 12.5% | 12.5% | 21.7% | 19.4% | 28.1% | 15.4% | 3.4% | 17.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.88 | 0.88 | 0.95 | 1.06 | 1.52 | 7.68 | 0.03 | 0.03 |
| Debt / EBITDA | 1.99 | 1.99 | 1.33 | 1.76 | 1.61 | 3.09 | 0.32 | 0.11 |
| Net Debt / Equity | — | 0.74 | 0.71 | 0.82 | 0.99 | 6.81 | -0.01 | -0.02 |
| Net Debt / EBITDA | 1.68 | 1.68 | 0.99 | 1.35 | 1.05 | 2.74 | -0.10 | -0.09 |
| Debt / FCF | — | 16.32 | 2.42 | 2.51 | 2.33 | 2.58 | -0.08 | -0.15 |
| Interest Coverage | 5.42 | 5.42 | 8.64 | 7.15 | 7.00 | 11.58 | 24.75 | 126.50 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.50 | 1.50 | 1.56 | 1.72 | 1.71 | 1.46 | 2.28 | 2.40 |
| Quick Ratio | 0.92 | 0.92 | 1.03 | 1.14 | 1.21 | 1.09 | 1.59 | 1.64 |
| Cash Ratio | 0.19 | 0.19 | 0.30 | 0.32 | 0.49 | 0.21 | 0.19 | 0.23 |
| Asset Turnover | — | 1.21 | 1.45 | 1.30 | 1.34 | 1.09 | 0.82 | 1.16 |
| Inventory Turnover | 6.26 | 6.26 | 7.85 | 6.95 | 7.20 | 7.68 | 5.64 | 5.95 |
| Days Sales Outstanding | — | 48.25 | 44.02 | 44.63 | 48.29 | 55.24 | 95.04 | 64.60 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.9% | 3.7% | 1.9% | 2.7% | 0.5% | — | — | — |
| Payout Ratio | 55.3% | 55.3% | 20.5% | 22.5% | 8.5% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.8% | 6.7% | 9.1% | 12.1% | 5.5% | 27.0% | — | — |
| FCF Yield | 3.0% | 2.2% | 7.5% | 14.0% | 13.4% | 39.1% | — | — |
| Buyback Yield | 5.6% | 4.2% | 2.1% | 3.3% | 3.7% | 0.0% | — | — |
| Total Shareholder Yield | 10.5% | 7.9% | 3.9% | 6.1% | 4.2% | 0.0% | — | — |
| Shares Outstanding | — | $41M | $42M | $43M | $44M | $44M | $44M | $44M |
Includes 30+ ratios · 7 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SLVM stock.
Sylvamo Corp's current P/E ratio is 11.4x. The historical average is 11.2x. This places it at the 60th percentile of its historical range.
Sylvamo Corp's current EV/EBITDA is 5.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 5.6x.
Sylvamo Corp's return on equity (ROE) is 14.6%. The historical average is 22.8%.
Based on historical data, Sylvamo Corp is trading at a P/E of 11.4x. This is at the 60th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Sylvamo Corp's current dividend yield is 4.86% with a payout ratio of 55.3%.
Sylvamo Corp has 21.9% gross margin and 7.4% operating margin.
Sylvamo Corp's Debt/EBITDA ratio is 2.0x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Secular demand decline and negative operating leverage
Metrics are mathematically derived from official filings.
Margin Compression Reflects Cyclical and Structural Pressures
Gross margin fell from 27.5% in 2024Q3 to 16.4% in 2026Q2, while operating margin dropped from 19.8% to 1.7%, per reported quarterly data, indicating severe margin erosion.
The 2026Q2 gross margin of 16.4% is roughly 11 percentage points below the 2024Q3 peak, and operating margin has collapsed to 1.7% from 19.8% over the same period. This suggests that the company's high fixed-cost structure is amplifying the impact of volume declines, as revenue fell 11.2% year-over-year. The recovery from the 2026Q1 trough (gross margin 11.1%, operating margin 0.4%) is tentative and may indicate that announced price increases are only partially offsetting cost and demand pressures. Investors should monitor whether margins can stabilize above the 2024 average of 24.9% gross and 14.2% operating, or if the secular decline in uncoated freesheet demand will keep margins structurally lower.
Return on Capital Decays as Asset Base Expands
ROIC fell from 8.9% in 2024Q3 to 0.6% in 2026Q2, while ROE turned negative at -1.1%, according to the latest quarterly data, reflecting deteriorating capital efficiency.
The sharp decline in ROIC from 8.9% to 0.6% over eight quarters indicates that the company is no longer generating adequate returns on its invested capital. This is partly due to a growing asset base—total assets rose from $2.6B to $2.9B—while operating income contracted, suggesting that capital expenditures are not translating into profitable growth. The negative ROE in 2026Q2 (-1.1%) is the first in the provided period, and it implies that the company is destroying shareholder value at the margin. The trend suggests that the company's competitive advantages, such as low-cost eucalyptus integration, are not sufficient to offset the cyclical downturn and structural demand erosion.
Working Capital Efficiency Deteriorates as Cash Conversion Lengthens
Cash conversion cycle extended from 45 days in 2024Q1 to 54 days in 2026Q2, driven by higher DIO (67 days) and DSO (43 days), based on reported quarterly figures.
The cash conversion cycle has lengthened by nine days over the period, primarily due to a rise in days inventory outstanding from 52 to 67 days, which may indicate slowing demand or inventory build-up. Days sales outstanding also increased from 45 to 43 days (though not monotonic), while days payable outstanding remained relatively stable around 53-56 days. This suggests that Sylvamo is holding inventory longer and collecting receivables more slowly, which ties up cash and reduces operational flexibility. The asset turnover ratio has also declined from 0.35 to 0.28, indicating that the company is generating less revenue per dollar of assets, consistent with the revenue contraction and asset expansion.
Leverage Creeps Higher as Interest Coverage Weakens
Debt-to-equity rose from 0.88 in 2025Q4 to 1.01 in 2026Q2, while interest coverage fell from 6.27x to 1.09x, according to the latest balance sheet data, signaling rising financial risk.
The increase in debt-to-equity to 1.01, coupled with a dramatic decline in interest coverage from 6.27x to 1.09x, indicates that the company's earnings are barely sufficient to cover interest expenses. This is a significant deterioration from the 2024Q4 coverage of 15.29x, and it suggests that the company is becoming more vulnerable to earnings shocks. The D/EBITDA ratio has also spiked to 16.91x in 2026Q2 from 4.02x in 2024Q4, reflecting both higher debt and lower EBITDA. While the balance sheet remains manageable, the trend warrants close monitoring, especially if the company continues to fund dividends and buybacks with debt during a downturn.
Liquidity Buffer Thins as Current Ratio Declines
Current ratio fell from 1.72 in 2024Q3 to 1.47 in 2026Q2, with cash dropping from $248M to $123M, based on reported balance sheet data, indicating a shrinking cushion.
The current ratio has declined steadily, and the quick ratio has fallen from 1.13 to 0.80, suggesting that the company's ability to cover short-term obligations with liquid assets is weakening. The drop in cash reserves from $248M to $123M, combined with negative free cash flow in some quarters, indicates that the company may be relying on debt or working capital reductions to fund operations. Under a severe stress scenario, such as a further 10% decline in revenue, the current ratio could fall below 1.0, potentially straining liquidity. However, the company's access to credit markets and its relatively low overall leverage (D/E of 1.01) may provide some buffer, though this is not guaranteed.
P/E Misleads in Cyclical Downturn
The trailing P/E of 11.92 appears low, but forward P/E of 20.31 suggests earnings are expected to recover; however, in a cyclical downturn, P/E can be misleadingly low, per current valuation data.
The most commonly misapplied ratio for Sylvamo is the price-to-earnings (P/E) multiple. With trailing earnings depressed, the P/E of 11.92 may appear attractive, but it is based on near-trough earnings and does not reflect the cyclicality of the paper industry. The forward P/E of 20.31 implies that the market expects earnings to recover significantly, which may be overly optimistic given the secular decline in uncoated freesheet demand. A more appropriate metric is EV/EBITDA, which at 5.24x (and 4.23x forward) is more stable and better captures the company's cash-generating ability before interest, taxes, depreciation, and amortization. Investors should also consider the price-to-book ratio (1.63) and the dividend yield (4.6%) to assess value, but the P/E should be used with caution in this cyclical context.